Novavax
NVAX
#5751
Rang
€0.96 Md
Capitalisation boursière
5,93 €
Prix de l'action
0.73%
Changement (1 jour)
-24.31%
Changement (1 an)

Novavax (NVAX) - Dette totale

Dette totale au bilan au Septembre 2025 : 0.21 Milliard d'euros

Selon les derniers rapports financiers de Novavax, la dette totale de l'entreprise est de 0.21 Milliard d'euros. La dette totale d'une entreprise est la somme de toutes les dettes courantes et non courantes.

Novavax - Dette totale au bilan (de 1999 à 2025)

Dette totale par année

Année Dette totale Changement
2024-12-31€0.22 Md6.85%
2023-12-31€0.20 Md-59.57%
2022-12-31€0.51 Md27.85%
2021-12-31€0.40 Md5.36%
2020-12-31€0.38 Md32.42%
2019-12-31€0.28 Md2.98%
2018-12-31€0.27 Md5.35%
2017-12-31€0.26 Md-11.94%
2016-12-31€0.30 Md83149.13%
2015-12-31€0.36 M-55.98%
2014-12-31€0.82 M-39.75%
2013-12-31€1.36 M49.52%
2012-12-31€0.91 M269.7%
2011-12-31€0.24 M-18.06%
2010-12-31€0.3 M-11.35%
2009-12-31€0.33 M-97.93%
2008-12-31€16.38 M5.17%
2007-12-31€15.58 M-11.34%
2006-12-31€17.57 M-31.81%
2005-12-31€25.77 M-5.93%
2004-12-31€27.39 M-18.2%
2003-12-31€33.49 M-15.44%
2002-12-31€39.6 M1.87%
2001-12-31€38.88 M83.14%
2000-12-31€21.23 M21263.27%
1999-12-31€0.09 M

Dette totale pour des entreprises similaires ou concurrentes

Entreprise Dette totale/th> Dette totale différencediff. Pays
Agenus
AGEN
€39.31 M-81.77%🇺🇸 USA
Sarepta Therapeutics
SRPT
€1.07 Md 397.81%🇺🇸 USA
Emergent BioSolutions
EBS
€0.56 Md 164.04%🇺🇸 USA
BioCryst Pharmaceuticals
BCRX
€0.55 Md 157.00%🇺🇸 USA
AstraZeneca
AZN
€28.02 Md 12,893.55%🇬🇧 UK
Pfizer
PFE
€52.26 Md 24,128.72%🇺🇸 USA
Novartis
NVS
€27.50 Md 12,650.66%🇨🇭 Switzerland
NanoViricides
NNVC
€1.28 M-99.40%🇺🇸 USA
GlaxoSmithKline
GSK
€20.49 Md 9,401.47%🇬🇧 UK
Celldex Therapeutics
CLDX
€2.25 M-98.96%🇺🇸 USA